{"id":"https://openalex.org/W4362398583","doi":"https://doi.org/10.1158/1078-0432.22458462","title":"Supplementary Figures from Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors","display_name":"Supplementary Figures from Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4362398583","doi":"https://doi.org/10.1158/1078-0432.22458462"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22458462","doi":"https://doi.org/10.1158/1078-0432.22458462","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22458462","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22458462","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102209007","display_name":"Shengjun Lu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shengjun Lu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107913622","display_name":"Jinyu Zhang","orcid":"https://orcid.org/0009-0005-8571-9368","observed_orcids":["https://orcid.org/0009-0005-8571-9368"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jinyu Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112115374","display_name":"Dai Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dai Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086997032","display_name":"Guangfu Li","orcid":"https://orcid.org/0000-0002-9817-568X","observed_orcids":["https://orcid.org/0000-0002-9817-568X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guangfu Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040371543","display_name":"Kevin F. Staveley-O\u2019Carroll","orcid":"https://orcid.org/0000-0003-2207-0379","observed_orcids":["https://orcid.org/0000-0003-2207-0379"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin F. Staveley-O'Carroll","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002360335","display_name":"Zihai Li","orcid":"https://orcid.org/0000-0003-4603-927X","observed_orcids":["https://orcid.org/0000-0003-4603-927X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zihai Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5101919644","display_name":"Jennifer D. Wu","orcid":"https://orcid.org/0000-0002-8925-268X","observed_orcids":["https://orcid.org/0000-0002-8925-268X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer D. Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.861299991607666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.861299991607666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.10329999774694443,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.02410000003874302,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6840000152587891},{"id":"https://openalex.org/keywords/t-bet","display_name":"T-bet","score":0.8180000185966492},{"id":"https://openalex.org/keywords/cd8-t-cell-responses","display_name":"CD8+ T cell responses","score":0.8579999804496765},{"id":"https://openalex.org/keywords/metastatic-cancer","display_name":"metastatic cancer","score":0.7300000190734863},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.5472809672355652},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5417270660400391},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.5285388827323914},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5128119587898254},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5009670257568359},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4399682283401489},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4206479489803314},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3759176433086395},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.32554739713668823},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.307717502117157},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.18008020520210266}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22458462","doi":"https://doi.org/10.1158/1078-0432.22458462","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22458462","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22458462","doi":"https://doi.org/10.1158/1078-0432.22458462","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22458462","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7222978970","https://openalex.org/W2398895934","https://openalex.org/W4361952391","https://openalex.org/W1979371667","https://openalex.org/W4404065335","https://openalex.org/W4308399178","https://openalex.org/W4415900146","https://openalex.org/W2237168462","https://openalex.org/W2567253817","https://openalex.org/W2593010745"],"abstract_inverted_index":{"Supplementary":[0,9,28,44,60,84,98,115,126],"Figure":[1,10,29,45,61,85,99,116,127],"1.":[2],"Basic":[3],"functional":[4],"characterization":[5],"of":[6,16,22,39,74,94,120,136],"B10G5":[7,26,33,47,89,121,140],"antibody.":[8],"2.":[11],"Changes":[12],"in":[13,109],"serum":[14],"levels":[15],"cytokines":[17],"and":[18],"chemokines":[19],"with":[20],"depletion":[21,135],"lymphocyte":[23],"subsets":[24],"during":[25,139],"therapy.":[27],"3.":[30],"Anti-sMIC":[31,87,101],"mAb":[32,88],"therapy":[34,48,90,102,141],"significantly":[35],"increase":[36],"homeostatic":[37],"proliferation":[38],"adoptively":[40],"transferred":[41],"NK":[42,137],"cells.":[43],"4.":[46],"did":[49],"not":[50],"impact":[51],"CD4":[52,143],"T":[53,69,106,144],"cell":[54,107,145],"homeostasis":[55],"but":[56],"increased":[57],"T-bet":[58],"expression.":[59],"S5.":[62],"Undetectable":[63],"endogenous":[64],"SV40TAg":[65],"epitope":[66,80],"I-specific":[67,81],"CD8":[68,105],"cells":[70,138],"shown":[71],"by":[72,77],"lack":[73],"positive":[75],"staining":[76],"H-2Db-restrcited":[78],"TAg":[79],"tetramer":[82],"(Db/I-Tetramer).":[83],"6.":[86],"inhibits":[91],"the":[92,110],"growth":[93],"transplantable":[95,111],"TRAMP-sMICB":[96],"tumors.":[97,125],"7.":[100],"enhanced":[103],"antigen-specific":[104],"responses":[108],"TRAMP-C2-sMICB-OVA":[112],"tumor":[113],"model.":[114],"8.":[117],"Therapeutic":[118],"effect":[119],"against":[122],"well-differentiated":[123],"TRAMP/MICB":[124],"S9.":[128],"Representative":[129],"flow":[130],"cytometry":[131],"analyses":[132],"demonstrating":[133],"that":[134],"impairs":[142],"Th1":[146],"responses.":[147]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2023-04-05T00:00:00"}